Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.
about
Immunological Evasion in GlioblastomaMacrophage-tumor cell interactions regulate the function of nitric oxideContribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice.Immunotherapy for malignant gliomaRegulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune systemA hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms.FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in GliomasAccumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumoniaIntragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusionsDepletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effectsSystemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and VaccinationPancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.The controversial role of microglia in malignant gliomas.Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma.Is HCMV a tumor promoter?Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.Cellular immunotherapy for high-grade glioma.Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance.Reactive oxygen species in the immune system.Myeloid-derived suppressor cells in glioma.The roles of myeloid-derived suppressor cells in transplantation.CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC.The Dynamics of Interactions Among Immune and Glioblastoma Cells.NOS Expression and NO Function in Glioma and Implications for Patient Therapies.Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotypeTowards a glioma model for surgical technique evaluation in the rat.Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response.TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function.Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas.Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.
P2860
Q26746612-B4A014DD-713B-408A-AD78-1BE352F6F686Q28384490-394EF369-EEBC-4727-B976-128D2F6B82C4Q33786677-ED51C168-B37A-46F4-9683-128DE2C7CBB4Q34811936-9C26202A-28E0-4F4E-94C8-5E5192470079Q35114086-97E2C8F7-406D-4D59-B823-C7A88A95FCFFQ35553553-36D5E85F-A138-42A1-8AB7-A4588CB7DB63Q35588431-CF9704BA-E5AF-446E-97B9-5B0FE917F0FDQ35884147-8DE6FF9B-4AE8-410D-A988-2131CA0B575FQ36009621-6DDCA625-BABA-4ECB-A9BD-A4A1E5254AFCQ36277369-F6386401-F192-4DDC-9722-99B5FC22B080Q36356879-F41B2889-03CA-4720-9CA5-8EC2D355F92CQ36493469-7E6EF4FE-7F8E-4098-9E96-BCE80EDEEA28Q36544980-408C29D7-8A30-4BBE-BCDE-4BE36C3FA39EQ36610868-36FAAA1B-5768-4669-9574-52740FCB8A30Q36781474-ACE70768-CAE9-45D8-9ABC-84E895E84412Q36971755-CDABB8AC-FCD5-4DC0-8B50-81DD01455ED2Q37091110-A68C7917-2C13-481E-B43E-F9674EF4C1D9Q37496791-4028B7E9-1EA0-48DF-950D-D5FEC67C2414Q37805181-6104669C-B1C4-4199-A0C3-3A965202B3EFQ37829504-33B20EB4-6208-4C62-AF8A-53DD0C2CD1E7Q37851972-E5F12856-AD5D-446A-B1F8-B109B07E9951Q38028470-E14B977E-3D52-45BE-9818-789EFCF4CA44Q38101671-37283D5B-8940-4ABE-A72E-CCA20A528716Q38161536-ECB1952B-5306-40D3-9DB5-65415F33F64AQ38239562-5CA2C53F-E91D-43D4-94D3-382D96B0E5D3Q38294011-88434909-B4F2-4B67-8050-79D2C23A75C3Q38557236-EE15C071-0094-4931-8692-85A41062B7F8Q38842322-89683B19-7CF6-48C2-9358-8D09151FA9F4Q38868808-9CF0A1A9-E737-4111-8FA4-3D0D0D6920F6Q39127847-FFBD3B86-AD7C-4B4F-AD65-74C585FA8340Q40116327-B41C4930-8B8C-40B6-B0EB-31202CC74741Q41968526-9C2C5BCE-53BA-46AE-B7A9-01173DC4210FQ42326772-C0B6293E-7EFC-4B0F-BFF3-7EB19F3632B0Q52649753-2F5A6017-7242-4D4B-A95B-C3F38F5FE811
P2860
Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tumor-infiltrating, myeloid-de ...... at glioma + vaccination model.
@ast
Tumor-infiltrating, myeloid-de ...... at glioma + vaccination model.
@en
type
label
Tumor-infiltrating, myeloid-de ...... at glioma + vaccination model.
@ast
Tumor-infiltrating, myeloid-de ...... at glioma + vaccination model.
@en
prefLabel
Tumor-infiltrating, myeloid-de ...... at glioma + vaccination model.
@ast
Tumor-infiltrating, myeloid-de ...... at glioma + vaccination model.
@en
P2093
P2860
P1476
Tumor-infiltrating, myeloid-de ...... at glioma + vaccination model.
@en
P2093
Colleen Jackson-Cook
Martin R Graf
Wentao Jia
P2860
P356
10.1016/J.JNEUROIM.2010.03.011
P577
2010-05-08T00:00:00Z